Table 2.
Unadjusted rate ratios (RR) for achieving a second CE-IM following recurrence by baseline characteristics and recurrence grade among 36 patients who experienced recurrence and had at least one additional surveillance endoscopy.
| Characteristic | Second CE-IM - N (%) | No Second CE-IM - N (%) | Unadjusted RR (95% CL) |
|---|---|---|---|
| Age (years) - 40 to 59 | 21 (70.0) | 5 (83.3) | Ref. |
| - 60 to 79 | 4 (13.3) | 1 (16.7) | 0.72 (0.24 – 2.88) |
| - 80 to 99 | 5 (16.7) | 0 (0.0) | 1.42 (0.31 – 7.14) |
| BMI (mg/kg2) - Normal (18.5 – 24.9) | 6 (20.0) | 0 (0.0) | Ref. |
| - Overweight (25.0 – 29.9) | 8 (26.7) | 3 (50.0) | 0.78 (0.24 – 2.73) |
| - Obesity (>=30) | 16 (53.3) | 3 (50.0) | 1.10 (0.41 – 3.44) |
| Female | 10 (33.3) | 1 (16.7) | Ref. |
| Male | 20 (66.7) | 5 (83.3) | 0.82 (0.37 – 1.96) |
| Prague M length (cm) - 0 to 3 | 6 (20.0) | 2 (33.3) | Ref. |
| - 4 or greater | 24 (80.0) | 4 (66.7) | 1.05 (0.42 – 3.13) |
| Prague C length (cm) - 0 to 3 | 24 (80.0) | 5 (83.3) | Ref. |
| - 4 or greater | 6 (20.0) | 1 (16.7) | 2.22 (0.74 – 5.58) |
| Baseline grade - Low-grade dysplasia | 8 (26.7) | 2 (33.3) | Ref. |
| - High-grade dysplasia | 21 (70.0) | 4 (66.7) | 1.58 (0.67 – 4.13) |
| - Intramucosal adenocarcinoma | 1 (3.3) | 0 (0.0) | 2.52 (0.06 – 18.82) |
| Recurrence grade – non-dysplastic | 11 (36.7) | 1 (16.7) | Ref. |
| - Low-grade dysplasia | 12 (40.0) | 3 (50.0) | 0.70 (0.28 – 1.76) |
| - High-grade dysplasia | 4 (13.3) | 1 (16.7) | 0.88 (0.20 – 2.96) |
| - Intramucosal Adenocarcinoma | 3 (10.0) | 1 (16.7) | 1.31 (0.23 – 4.97) |
| Non-dysplastic recurrence | 11 (36.7) | 1 (16.7) | Ref. |
| - Dysplastic recurrence | 19 (63.3) | 5 (83.3) | 0.79 (0.36 – 1.85) |
BMI, body mass index.